MMED vs BLCO
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
MMED · MiniMed Group$16.71 ▼ 7.96%
BLCO · Bausch + Lomb Corp.$19.99 ▲ 0.35%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- MMED -9.6%
- BLCO +17.2%
Head to head
| Metric | MMED | BLCO |
|---|---|---|
| Price | $16.71 | $19.99 |
| Change today | ▼ 7.96% | ▲ 0.35% |
| Market cap | $4.70B | $7.15B |
| Return, 3 months | -14.3% | +18.8% |
| Return, year to date | – | +17.0% |
| Return, 1 year | – | +28.6% |
| P/E (TTM) | -14.8 | -62.5 |
| P/B | 1.3 | 1.1 |
| P/E percentile vs own 5y | 30th | 4th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +16.6% | +7.3% |
| Net profit growth (YoY) | +100.0% | +240.0% |
| Gross margin | 53.9% | 62.6% |
| Operating margin | -5.0% | 9.4% |
| Net margin | -9.7% | -2.0% |
| Return on equity | -8.7% | -1.7% |
| Analyst target vs. price | +59.1% | +12.2% |
| Analyst buy share | 85% | 63% |
| RSI (14) | 36 | 67 |
| 30-day volatility | 57.3% | 52.6% |
| Max drawdown, 1 year | -41.6% | -20.1% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- BLCO is the largest of the group by market value.
- BLCO carries the lowest trailing P/E.
- MMED is growing revenue fastest.
- BLCO keeps the most profit per dollar of sales.
- BLCO has been the calmest stock over the last 30 days.